Furthermore, in AD, although amyloid-beta and Tau proteins are the primary pathological markers, α-synuclein often co-aggregates with these proteins, potentially exacerbating neurodegenerative processes and contributing to synaptic dysfunction and cognitive decline [50,51]. This evidence concerns the gene MAPT and Alzheimer disease.